Compass Biotechnologies Inc. (COBI) Financial Statements (2023 and Earlier)
9650 - 20 AVENUE
EDMONTON, AB T6N 1G1
|State of Incorp.||NV|
|Fiscal Year End||January 31|
|Industry (SIC)||2834 - Pharmaceutical Preparations (benchmarking)|
|More info||Complete financial analysis Financial benchmarking|
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.